(Q58946500)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Use of phosphate-binding agents is associated with a lower risk of mortality (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

Jorge B Cannata-andía

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

José Luis Fernández-Martín

4 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Anibal Ferreira

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Willem Jan W Bos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Judit Nagy

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Drasko Pavlovic

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Pablo Martínez-Camblor

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Pablo Martínez Camblor

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Juan J Carrero

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Carmine Zoccali

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

9

Adrian Covic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

10

Boleslaw Rutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Manuel Naves-Díaz

26

0 references

Vladimír Teplan

Vladimir Teplan

13

0 references

Christian Tielemans

15

Christian Tielemans

1 reference

4 March 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

Dierik Verbeelen

16

Dierik Verbeelen

1 reference

4 March 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

Francesco Locatelli

3

Francesco Locatelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Gérard London

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jürgen Floege

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Markus Ketteler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Dimitrios Memmos

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

David Goldsmith

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Reinhard Kramar

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Pierre-Yves Martin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Miha Benedik

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

José Emilio Sánchez

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

José L Gorriz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rudolf P Wüthrich

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

3 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

998-1008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2013.185

4 March 2020

exact match

0 references

cites work

50 years of research and discovery in chronic kidney disease and mineral & bone disorder: the central role of phosphate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Phosphorus and survival: key questions that need answers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Mineral and bone disease pattern in elderly haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Vascular calcification in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Phosphorus comes of age as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Ten-year experience with sevelamer and calcium salts as phosphate binders.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Phosphorus binders and survival on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Increasing Body Mass Index and Obesity in the Incident ESRD Population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Oral active vitamin D is associated with improved survival in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

International hemodialysis patient outcomes comparisons revisited: the role of practice patterns and other factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Serum phosphate and mortality in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Aluminium toxicity: its relationship with bone and iron metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

The clinical impact of aluminium overload in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Calcium in chronic kidney disease: myths and realities. Introduction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Efficacy and safety of SBR759, a new iron-based phosphate binder

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Phosphate binders in a European haemodialysis population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.185

7 January 2021

Identifiers

DOI

10.1038/KI.2013.185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23823605%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference